SkyLab Bio is a UK-based biotechnology startup that employs novel functional assays designed to thoroughly characterise and classify gene regulatory sequence (non-coding) variants.  

These assays permit the rapid functional dissection of thousands of regulatory variants in a relevant biological setting, the results of which can be used by clinical experts to evaluate a patient’s risk of developing disease and inform personalised therapy.